Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Assumes Bitfarms Ltd. (BITF) at Overweight
-
Cantor Fitzgerald Assumes Terawulf Inc. (WULF) at Overweight
-
Cantor Fitzgerald Assumes CleanSpark Inc. (CLSK) at Overweight
-
Cantor Fitzgerald Assumes Cipher Mining (CIFR) at Overweight
-
Cantor Fitzgerald Assumes Riot Platforms (RIOT) at Overweight
-
Cantor Fitzgerald Assumes Bitdeer Technologies Group (BTDR) at Overweight
-
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
-
Form N-CSR CANTOR FITZGERALD INFRAS For: Mar 31
-
Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA)
-
Newmark Announces Launch of Exchange Offer For Its 7.500% Senior Notes Due 2029
-
NVIDIA (NVDA) PT Lowered to $140 at Cantor Fitzgerald, 'remains our TOP PICK in semis'
-
Gold Reserve Inc. Closes US$15.0M Private Placement
-
Cantor Fitzgerald Downgrades PowerSchool Holdings Inc. (PWSC) to Neutral
-
Form 8-K Cantor Fitzgerald Income For: Jun 06
-
Cantor Fitzgerald Downgrades Sprinklr Inc (CXM) to Neutral
-
Cantor Fitzgerald Reiterates Overweight Rating on CrowdStrike Holdings (CRWD)
-
Cantor Fitzgerald Starts Proto Labs (PRLB) at Overweight
-
Cantor Fitzgerald Starts Xometry Inc (XMTR) at Underweight
-
GitLab Inc (GTLB) PT Lowered to $55 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicycle Therapeutics (BCYC)
-
Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
-
Western Smokehouse Partners, a Portfolio Company of AUA Private Equity, Acquires Golden Valley Natural
-
Bitdeer Technologies (BTDR) Announces $150M Share and Warrant Offering
-
Bitdeer Announces Up to $150 Million Private Placement Financing
-
Zscaler (ZS) PT Lowered to $200 at Cantor Fitzgerald
-
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
-
Cantor Fitzgerald Starts Rubrik Inc (RBRK) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
-
Form NPORT-P CANTOR FITZGERALD INFRAS For: Mar 31
-
Cantor Fitzgerald Starts ADC Therapeutics (ADCT) at Overweight
-
Cantor Fitzgerald Starts Codexis, Inc. (CDXS) at Overweight
-
Point and Atalaya Capital Management Close Oversubscribed $141 Million Home Equity Investment Rated Securitization
-
Maxim Group Continues Growth in its Institutional Sales and Trading Division with Hiring of John Novak
-
Gold Reserve Provides Update on Previously Announced Best Efforts Private Placement
-
Origin Investments Launches Origin Exchange
-
McEwen Mining Announces Flow-Through Financing at $14.36 (Cdn$19.59) per Share a 19% Premium to Market
-
Zefiro Methane CCO Tina Reine Featured as a Panelist at the Argus Europe Carbon Conference
-
Gold Reserve Announces up to US$65 Million in Financing Transactions in Connection With a Potential Bid in Relation to the Sale of the Shares of PDV Holdings, Inc., Under the Delaware Proceedings
-
Fannie Mae Prices $708 Million Connecticut Avenue Securities (CAS) REMIC Deal
-
Nyxoah (NYXH) Prices 5.37M Share Offering at $9.25/sh
-
Nyxoah Announces Pricing of Offering
-
NVIDIA (NVDA) PT Raised to $1,400 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Skye Bioscience (SKYE) at Overweight
-
Nyxoah Announces Proposed Offering of Ordinary Shares
-
Cantor Fitzgerald Reiterates Overweight Rating on CyberArk Software (CYBR)
-
Cantor Fitzgerald Downgrades Ouster Inc. (OUST) to Neutral
-
InTandem Capital Partners Announces Investment in Adams Clinical
-
Rubicon Technologies Inc (RBT) PT Lowered to $0.60 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Palo Alto Networks (PANW)
-
Cantor Fitzgerald Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Overweight, 'biotech stock to own'

